Inga Harbuz-Miller retweeted
Primary Aldosteronism is very common
This interactive case reviews how to recognize it, avoid pitfalls, and effectively help your patients @NEJM
nejm.org/doi/full/10.10…
(free access with login)
This interactive case reviews how to recognize it, avoid pitfalls, and effectively help your patients @NEJM
nejm.org/doi/full/10.10…
(free access with login)
1
85
253
20,497
A very important topic was discussed today during Medicine Grand Round @URMC_DeptMed by #Dr.SamuelDennis @URMC_ENDO . #Gestationaldiabetes
0
0
1
192
Inga Harbuz-Miller retweeted
It was a great honor to launch the 2 adrenal preceptorship from the @endocrinefellow foundation. We have > 55 fellows from country at the @ClevelandClinic . Thanks to our amazing speakers @IrinaBancos (co-director) @tutihami oksanahamidi @AnandVaidya17 @pratibharao Lucindagruber
2
4
38
2,550
Inga Harbuz-Miller retweeted
Join Drs Mulatero and Brown as they debate #PrimaryAldosteronism detection - formal testing vs empiric treatment @TheEndoSociety #CEU now. images.app.goo.gl/3Ne6WXEjazryHp…
0
6
13
1,344
We kickstarted the Endocrine Grand Rounds @URMC_ENDO with a very insightful talk about MACS with our delightful guest @IrinaBancos from @MayoClinic No flight cancelations, time zones differences or zoom crashes can stop the science! Thank you Dr. Bancos!
0
2
21
1,246
Inga Harbuz-Miller retweeted
Welireg (Belzutifan) is officially approved for use in Australia! 🎉
Improving access to VHL treatment options through advocacy and education continues to be a top priority for the Alliance. Congratulations to our partners in Australia!
buff.ly/3T36csm
Improving access to VHL treatment options through advocacy and education continues to be a top priority for the Alliance. Congratulations to our partners in Australia!
buff.ly/3T36csm
1
3
9
373
Inga Harbuz-Miller retweeted
Did you miss IAES 2024 in Kuala Lumpur? Me, too.😢BUT I was able to record my talk and send it. Silver lining? You can see the IAES State of the Art lecture on Adrenal Cancer, too. 30min. Link: youtu.be/OGDgMJIQQFw
3
12
28
7,879
Inga Harbuz-Miller retweeted
🚨🗞️ Check out the new @biorxivpreprint study on #Dlk1 as novel #adrenocortical progenitor cell marker and predictor of malignancy in #adrenal #cancer - coordinated by @GuastiL @QMUL in collaboration with @EndoWue @AltieriBarbara and many others! @ENSAT_news @A5_Adrenal
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma biorxiv.org/cgi/content/sh… #biorxiv_cancer
0
3
18
1,294
Inga Harbuz-Miller retweeted
Today starts the 5th annual #pheo #para awareness week sponsored by @PheoPara. Please know the facts. If you don’t screen for it, you won’t find it. Plasma Mets. Once it’s found, genetics for all and follow up for life. #PheoParaDoc #mysteriouspheo #IDoIt4MyPatients #MyfavT
0
2
8
371
Inga Harbuz-Miller retweeted
🆕🚨 Delighted to see this work published in @WileyGlobal @clintransmed. We unveiled cellular diversity within the adult human #adrenalgland, identifying new cell populations and key pathways governing #adrenal homeostasis. A thread 🧵 dx.doi.org/10.1002/ctm2.1…
2
11
43
3,892
Inga Harbuz-Miller retweeted
Awareness Week Chair Chad Riding kicks off a series of events marking 2024 #Pheo #Para AW! Joined by Dr. Dhaval Patel @divot999, they explore the curious case of Mina Roll--an unsolved medical mystery from 1886. Did they solve it? 🔎Tune in to find out!
👉bit.ly/4dR6mLC
👉bit.ly/4dR6mLC
1
5
10
462
Right there with you!
@DrGaryHammer @Paris2024 Love the thread and I’d love to add to the collection! 🤗
0
0
9
344
Inga Harbuz-Miller retweeted
Important reading for ALL clinicians who prescribe glucocorticoids: avoid pitfalls and unnecessary consults, learn the basic pearls and advanced strategies for glucocorticoid management.
Summary below, full guideline link here: academic.oup.com/ejendo/article…
Summary below, full guideline link here: academic.oup.com/ejendo/article…
A new #guideline addresses glucocorticoid-induced adrenal insufficiency, with specific recommendations for tapering steroid therapy. jwat.ch/46fkf3p
1
12
35
3,810
Inga Harbuz-Miller retweeted
Join in a discussion of clinical trials 🔬for #pheo #para. It's a PHabulous opportunity to connect with an expert in the field.
Register & submit your Qs for Dr. @JaydiDelRivero
➡️bit.ly/4czdxI7
@RareDiseases @LACNETS @PheoParaProj @netcancerday @RonnyAllan1 @NANETS1
Register & submit your Qs for Dr. @JaydiDelRivero
➡️bit.ly/4czdxI7
@RareDiseases @LACNETS @PheoParaProj @netcancerday @RonnyAllan1 @NANETS1
0
6
9
556
Full house with excited new fellows and seasoned second and third year fellows ready to kickstart the new academic year with diabetes emergencies. @URMC_ENDO @IShafiq10 @StephenHammes @female_dr_
2
2
7
359
Done!
Takes less than 1 min to notify Congress that we oppose the cuts to @NIH funding. Biomedical research is already struggling. Can’t afford more cuts.
Click link below in @TheEndoSociety tweet to campaign against these cuts.
They make it so easy!
0
0
2
243
Inga Harbuz-Miller retweeted
Help our leaders plan the best possible #ENDO2025 in San Francisco, CA! Submit your session suggestions that you would like to see at next year's meeting by Monday, July 25: bit.ly/3VusDr1 @StephenHammes @KateFryer5 #endocrinology #hormonescience
1
9
23
3,862
Inga Harbuz-Miller retweeted
A Rare Case of Paraganglioma Syndrome Associated With Polycythemia and Blindness cureus.com/articles/20698…
Congratulations #DrEsaki on the publication.
Congratulations #DrEsaki on the publication.
7
1
5
302